Kevin K. Gordon joined the Veracyte board in December 2016. Mr. Gordon has served as President and Chief Financial Officer of Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, since January 2018. Prior to that, Mr. Gordon served as Executive Vice President and Chief Operating Officer of Quintiles Transnational Holdings Inc., a research, clinical trial and pharmaceutical consulting company, from October 2015 until October 2016 and served as Executive Vice President and Chief Financial Officer from July 2010 to December 2015 (Quintiles Transitional Holdings merged with IMS Health Holdings, Inc., an information and technology services company, in October 2016 to form IQVIA Holdings, Inc., a global biopharmaceutical services provider). Prior to that, Mr. Gordon spent 13 years in senior leadership positions at Teleflex Incorporated (NYSE: TFX), a diversified global company with over $2 billion in annual revenue, where he served as Executive Vice President and CFO from March 2007 to January 2010. He previously held senior management positions at KPMG. He holds a B.S. in Accounting from the University of Connecticut.
Kevin K. Gordon